141
4.9 Starting the therapy and seal level
WARNING
Regular patient monitoring
• Careful and regular patient monitoring is absolutely essential, particularly
in patients with heavily exuding wounds, wounds with viscous or heavily
sedimenting exudate and at risk of severe bleeding (see precautionary
measures in Section 1.4.3).
• In this situation, special attention should be given to exudate accumulated
inthe wound dressing and the correct positioning of the wound dressing.
• The monitoring interval must be determined based on the wound situation,
the patient’s general condition and the sensitivity settings.
WARNING
If bleeding occurs
The Suprasorb
®
CNP P3 was designed to generate negative pressure
inthewound drainage system and to suction exudate.
• The Suprasorb
®
CNP P3 was not designed to detect heavy bleeding
orpooling of blood in the wound.
• For this reason, you should not rely on the Suprasorb
®
CNP P3’s alarm
system alone. The therapy must be regularly monitored and the exudate
regularly checked for red discolouration so as to identify any risk of severe
deterioration in the patient’s condition.
• Should you observe bright red blood in the tubes or exudate pouch,
thetherapy must be discontinued immediately. Leave the wound dressing
inplace at first, stem the bleeding and seek medical assistance.
WARNING
Interruption of therapy
• Should it prove necessary to interrupt the therapy and switch the
Suprasorb
®
CNP P3 to Pause mode, this interruption should notbe
forlonger than two hours at atime within aperiod of 24 hours.
Thetherapymust be continued after max. two hours. If the therapy
isinterrupted for longer than two hours, the dressing must be changed
beforeit can be restarted.
Press now to start the therapy.
The screen goes green and the current pressure is shown. The seal level can be seen on
theright at the bottom of the screen. It serves as aguide for how tightly the dressing is sealed.
To Next Page
Loading...
Need help?
General